New developments in the treatment of systemic vasculitis

Immunology and Microbiology

• Vasculitis 100%
• Glucocorticoid 50%
• Granulomatosis with Polyangiitis 50%
• Monoclonal Antibody 25%
• Systemic Lupus Erythematosus 25%
• Interferon Alfa 25%
• Hepatitis C Virus 25%
• CD4 25%
• Serine 25%
• Immunosuppressive Therapy 25%
• Leukocytoclastic Vasculitis 25%
• Proinflammatory Cytokine 25%
• Glomerulonephritis 25%
• Drug Megadose 25%
• Intravenous Immunoglobulin 25%
• Cryoglobulinemia 25%
• Immune Complex Disease 25%
• Pentoxifylline 25%

Medicine and Dentistry

• Granulomatosis with Polyangiitis 50%
• Cyclophosphamide 50%
• Glucocorticoid 50%
• Disease Course 25%
• Morbidity 25%
• Drug Megadose 25%
• Immunoglobulin 25%
• Low Drug Dose 25%
• Immunosuppressive Treatment 25%
• Glomerulonephritis 25%
• Cryoglobulinemia 25%
• Hypersensitivity Angiitis 25%
• Serine Proteinase 25%
• Cytokine 25%
• Pulse Rate 25%
• Monoclonal Antibody 25%
• Methotrexate 25%
• Immune Complex Disease 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Glucocorticoid 50%
• Wegener Granulomatosis 50%
• Immunosuppressive Agent 25%
• Remission 25%
• Alpha Interferon 25%
• Methotrexate 25%
• Kidney Disease 25%
• Immune Complex Disease 25%
• Nafamstat Mesilate 25%
• Cytokine 25%
• Glomerulonephritis 25%
• Immunoglobulin 25%
• Disease Course 25%
• Hepatitis C Virus 25%
• Serine Proteinase 25%
• Monoclonal Antibody 25%
• Morbidity 25%
• Cryoglobulinemia 25%
• Leukocytoclastic Vasculitis 25%